Huntington James A
Department of Haematology, University of Cambridge, Division of Structural Medicine, Thrombosis Research Unit, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, UK.
Biol Chem. 2008 Aug;389(8):1025-35. doi: 10.1515/BC.2008.113.
Thrombin is the ultimate coagulation factor; it is the final protease generated in the blood coagulation cascade and is the effector of clot formation. Regulation of thrombin activity is thus of great relevance to determining the correct haemostatic balance, with dysregulation leading to bleeding or thrombosis. One of the most enigmatic and controversial regulators of thrombin activity is the monovalent cation Na+. When bound to Na+, thrombin adopts a 'fast' conformation which cleaves all procoagulant substrates more rapidly, and when free of Na+, thrombin reverts to a 'slow' state which preferentially activates the protein C anticoagulant pathway. Thus, Na+-binding allosterically modulates the activity of thrombin and helps determine the haemostatic balance. Over the last 30 years, there has been much research investigating the structural basis of thrombin allostery. Biochemical and mutagenesis studies established which regions and residues are involved in the slow-->fast conformational change, and recently several crystal structures of the putative slow form have been solved. In this article, the biochemical and crystallographic data are reviewed to see if we are any closer to understanding the conformational basis of the Na+ activation of thrombin.
凝血酶是最终的凝血因子;它是血液凝固级联反应中产生的最终蛋白酶,也是凝块形成的效应物。因此,凝血酶活性的调节对于确定正确的止血平衡至关重要,调节异常会导致出血或血栓形成。凝血酶活性最神秘且具争议性的调节因子之一是单价阳离子Na⁺。当与Na⁺结合时,凝血酶呈现“快速”构象,能更快速地切割所有促凝血底物;而当游离于Na⁺时,凝血酶恢复为“慢速”状态,优先激活蛋白C抗凝途径。因此,Na⁺结合通过变构调节凝血酶的活性,并有助于确定止血平衡。在过去30年里,有许多研究探讨了凝血酶变构的结构基础。生化和诱变研究确定了参与慢速→快速构象变化的区域和残基,最近还解析了假定慢速形式的几个晶体结构。在本文中,对生化和晶体学数据进行了综述,以查看我们是否更接近于理解Na⁺激活凝血酶的构象基础。